Concord Biotech has completed NAFDAC inspection (National Agency for Food and Drug Administration) at its Oral Solid Dosage (OSD) Unit-2, facility located at Valthera, Gujarat. The inspection was conducted from October 06, 2025 to October 07, 2025.
This achievement underscores its unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance across all aspects of its operations.
Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
